19-11012946-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000592604.6(SMARCA4):n.603C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,461,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000592604.6 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCA4 | NM_001387283.1 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 15 of 35 | ENST00000646693.2 | NP_001374212.1 | ||
| SMARCA4 | NM_003072.5 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 15 of 34 | ENST00000344626.10 | NP_003063.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 15 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
| SMARCA4 | ENST00000344626.10 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 15 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
| SMARCA4 | ENST00000643549.1 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 15 of 34 | ENSP00000493975.1 | |||||
| SMARCA4 | ENST00000541122.6 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 16 of 34 | 5 | ENSP00000445036.2 | ||||
| SMARCA4 | ENST00000643296.1 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 15 of 33 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 15 of 33 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000589677.5 | c.2275-3C>T | splice_region_variant, intron_variant | Intron 16 of 34 | 5 | ENSP00000464778.1 | ||||
| SMARCA4 | ENST00000643995.1 | c.1687-3C>T | splice_region_variant, intron_variant | Intron 12 of 31 | ENSP00000496004.1 | |||||
| SMARCA4 | ENST00000644963.1 | c.919-3C>T | splice_region_variant, intron_variant | Intron 8 of 27 | ENSP00000495599.1 | |||||
| SMARCA4 | ENST00000644065.1 | c.1000-3C>T | splice_region_variant, intron_variant | Intron 8 of 26 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000642350.1 | c.760-3C>T | splice_region_variant, intron_variant | Intron 7 of 26 | ENSP00000495355.1 | |||||
| SMARCA4 | ENST00000643857.1 | c.628-3C>T | splice_region_variant, intron_variant | Intron 6 of 24 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251442 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461836Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1Benign:1
- -
The SMARCA4 c.2275-3C>T intronic change results from a C to T substitution at the -3 position of intron 15 of the SMARCA4 gene. Algorithms that predict the impact of sequence changes on splicing indicate that this variant does not affect splicing, but to our knowledge these predictions have not been confirmed by RNA studies. This variant has a maximum subpopulation frequency of 0.0062% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). To our knowledge, this variant has not been reported in individuals with rhabdoid tumor predisposition syndrome. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Intellectual disability, autosomal dominant 16 Uncertain:1
- -
Rhabdoid tumor predisposition syndrome 2;C3553249:Intellectual disability, autosomal dominant 16 Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.2275-3C>T intronic variant results from a C to T substitution 3 nucleotides upstream from coding exon 15 in the SMARCA4 gene. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Based on the available evidence, the clinical significance of this variant remains unclear. -
SMARCA4-related disorder Uncertain:1
The SMARCA4 c.2275-3C>T variant is predicted to interfere with splicing. To our knowledge, this variant has not been reported in the literature. This variant is reported in 1 of ~251,000 alleles in gnomAD (http://gnomad.broadinstitute.org/variant/19-11123622-C-T). This variant is interpreted as uncertain significance in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/238398/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at